1 not yet recruiting. .
Follow xuliang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer Inavolisib in Combination With ET, Inavolisib in Combination With ET+CDK4/6i - Breast Cancer | Not yet recruiting | xuliang | 100 | 2026-05-16 | 2026-04-21 |
Breast Neoplasms (1)
inavolisib (1)